Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances

被引:58
作者
Chaudhry, Farrukh A. [1 ,2 ]
Edwards, Robert H. [4 ]
Fonnum, Frode [3 ]
机构
[1] Univ Oslo, Ctr Biotechnol, N-0317 Oslo, Norway
[2] Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway
[3] Univ Oslo, Dept Biochem, Inst Basic Med Sci, N-0317 Oslo, Norway
[4] Univ Calif San Francisco, Sch Med, Dept Neurol & Physiol, San Francisco, CA 94143 USA
关键词
VMAT; VAChT; VGAT; VGLUTs; synaptic vesicles; vesicular transporters;
D O I
10.1146/annurev.pharmtox.46.120604.141146
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exocytotic release of neurotransmitters requires their accumulation inside preformed secretory vesicles. Distinct vesicular transport activities translocate classical transmitters into synaptic vesicles energized by a H+ electrochemical gradient (Delta mu(H+)), with subtle but important differences in dependence on the electrical and chemical components. The vesicular transporters also interact with toxic compounds and drugs. They mediate neuroprotection by sequestering toxic compounds as well as neurotransmitters into vesicles, reducing their concentration in the cytosol where they may have detrimental effects. Both therapeutic agents and psychostimulants interfering with vesicular transport have yielded insight into the pathogenesis of psychiatric as well as neurodegenerative diseases. Thus, specific inhibitors have helped to characterize both the physiological role and mechanism of vesicular neurotransmitter transport.
引用
收藏
页码:277 / 301
页数:25
相关论文
共 148 条
  • [1] Ionic currents mediated by a prokaryotic homologue of CLC Cl- channels
    Accardi, A
    Kolmakova-Partensky, L
    Williams, C
    Miller, C
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2004, 123 (02) : 109 - 119
  • [2] Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells
    Adamson, CR
    Emley, TE
    Herbig, LJ
    Near, JA
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (4-5) : 411 - 415
  • [3] SEVERE HYPOGLYCEMIA LEADS TO ACCUMULATION OF ARACHIDONIC-ACID IN BRAIN-TISSUE
    AGARDH, CD
    WESTERBERG, E
    SIESJO, BK
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1980, 109 (01): : 115 - 116
  • [4] THE CAENORHABDITIS-ELEGANS UNC-17 GENE - A PUTATIVE VESICULAR ACETYLCHOLINE TRANSPORTER
    ALFONSO, A
    GRUNDAHL, K
    DUERR, JS
    HAN, HP
    RAND, JB
    [J]. SCIENCE, 1993, 261 (5121) : 617 - 619
  • [5] ANDERSEN IS, 2006, ORGANOBALOGEN COMPOU, V68, P1182
  • [6] UNCOUPLING OF ACETYLCHOLINE UPTAKE FROM THE TORPEDO CHOLINERGIC SYNAPTIC VESICLE ATPASE
    ANDERSON, DC
    KING, SC
    PARSONS, SM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (02) : 422 - 428
  • [7] ANDERSON DC, 1983, MOL PHARMACOL, V24, P48
  • [8] Methylmercury alters glutamate transport in astrocytes
    Aschner, M
    Yao, CP
    Allen, JW
    Tan, KH
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2000, 37 (2-3) : 199 - 206
  • [9] A KINETIC AND ALLOSTERIC MODEL FOR THE ACETYLCHOLINE TRANSPORTER-VESAMICOL RECEPTOR IN SYNAPTIC VESICLES
    BAHR, BA
    CLARKSON, ED
    ROGERS, GA
    NOREMBERG, K
    PARSONS, SM
    [J]. BIOCHEMISTRY, 1992, 31 (25) : 5752 - 5762
  • [10] DEMONSTRATION OF A RECEPTOR IN TORPEDO SYNAPTIC VESICLES FOR THE ACETYLCHOLINE STORAGE BLOCKER L-TRANS-2-(4-PHENYL[3,4-H-3]-PIPERIDINO)CYCLOHEXANOL
    BAHR, BA
    PARSONS, SM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) : 2267 - 2270